Display options
Cite
Alexopoulos GS, Bruce ML, Silbersweig D, et al. Vascular depression: a new view of late-onset depression. Dialogues Clin Neurosci. 1999;1(2):68-80
Alexopoulos, G. S., Bruce, M. L., Silbersweig, D., Kalayam, B., & Stern, E. (1999). Vascular depression: a new view of late-onset depression. Dialogues in clinical neuroscience, 1(2), 68-80.
Alexopoulos, G S, et al. "Vascular depression: a new view of late-onset depression." Dialogues in clinical neuroscience vol. 1,2 (1999): 68-80.
Alexopoulos GS, Bruce ML, Silbersweig D, Kalayam B, Stern E. Vascular depression: a new view of late-onset depression. Dialogues Clin Neurosci. 1999 Sep;1(2):68-80. PMID: 22033775; PMCID: PMC3181568.
Copy Download .nbib Format: NLM
Share it on

Dialogues Clin Neurosci. 1999 Sep;1(2):68-80.

Vascular depression: a new view of late-onset depression.

Dialogues in clinical neuroscience

G S Alexopoulos, M L Bruce, D Silbersweig, B Kalayam, E Stern

Affiliations

  1. Weill Medical College of Cornell University, White Plains, NY, USA. Professor of Psychiatry, Director Cornell Institute of Geriatric Psychiatry.

PMID: 22033775 PMCID: PMC3181568

Abstract

We have suggested that cerebrovascular disease may predispose, precipitate, or perpetuate some late-life depressive syndromes. The mechanisms of "vascular depression" include disruption of cortico-striato-pallido-thalamo-cortical (CSPTC) pathways or their modulating systems. This view is supported by the presentation of vascular depression, which consists of depressive symptoms, cognitive abnormalities, as well as neuroimaging findings that may result from CSPTC impairment. Moreover, clinical and electrophysiological evidence of CSPTC impairment, an abnormality frequently found in patients with vascular depression, appears to be associated with poor response to antidepressant treatment and early relapse and recurrence. The vascular depression hypothesis provides the conceptual background for studies that may have clinical and theoretical impact. Agents influencing dopamine, acetylcholine, and opioid neurotransmitters may be studied in vascular depression, since these are essential neurotransmitters of the frontostriatal circuitry. Drugs used for prevention and treatment of cerebrovascular disease may be shown to reduce the risk for vascular depression or improve its outcomes. The choice of antidepressants in vascular depression may depend on their effect on neurological recovery from ischemic lesions. Finally, identification of specific relationships between specific symptoms, cognitive deficits, and disability may lead to interventions that target the patients' deficits as well as their interactions with psychosocial factors known to contribute to depression. Research can clarify the pathways to vascular depression by focusing on the site of lesion, the resultant brain dysfunction, the presentation of depression and time of onset, and the contribution of nonbiological factors.

Keywords: disability; recovery from ischemia; treatment resistance; vascular depression

References

  1. Am J Psychiatry. 1997 Apr;154(4):562-5 - PubMed
  2. J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):428-42 - PubMed
  3. Arch Gen Psychiatry. 1989 Mar;46(3):243-50 - PubMed
  4. JAMA. 1992 Aug 26;268(8):1018-24 - PubMed
  5. J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1347-54 - PubMed
  6. Med Clin North Am. 1988 Jul;72(4):847-66 - PubMed
  7. Psychopharmacology (Berl). 1992;106(3):311-4 - PubMed
  8. Neurology. 1996 Feb;46(2):301-7 - PubMed
  9. Br J Psychiatry. 1981 Oct;139:288-92 - PubMed
  10. Arch Neurol. 1991 Nov;48(11):1136-40 - PubMed
  11. J Affect Disord. 1988 Jul-Aug;15(1):61-8 - PubMed
  12. Neurology. 1996 Jan;46(1):154-9 - PubMed
  13. Psychiatry Res. 1991 Oct;40(2):95-9 - PubMed
  14. J Geriatr Psychiatry Neurol. 1995 Apr;8(2):96-9 - PubMed
  15. Stroke. 1993 Jul;24(7):976-82 - PubMed
  16. Biol Psychiatry. 1988 Mar 1;23(5):519-22 - PubMed
  17. Am J Psychiatry. 1990 Feb;147(2):187-9 - PubMed
  18. JAMA. 1997 Mar 12;277(10):813-7 - PubMed
  19. AJNR Am J Neuroradiol. 1994 Oct;15(9):1625-33 - PubMed
  20. Arch Gen Psychiatry. 1992 Jul;49(7):553-7 - PubMed
  21. J Neurol Neurosurg Psychiatry. 1992 Sep;55(9):768-73 - PubMed
  22. Am J Psychiatry. 1993 Dec;150(12):1806-12 - PubMed
  23. Am J Psychiatry. 1980 Apr;137(4):439-44 - PubMed
  24. Arch Gen Psychiatry. 1999 Aug;56(8):713-8 - PubMed
  25. J Am Geriatr Soc. 1996 Mar;44(3):237-41 - PubMed
  26. Stroke. 1996 Jul;27(7):1211-4 - PubMed
  27. Lancet. 1994 Mar 19;343(8899):687-91 - PubMed
  28. Ann Neurol. 1982 Nov;12(5):463-8 - PubMed
  29. Neurology. 1989 Mar;39(3):349-54 - PubMed
  30. Br J Psychiatry. 1989 Jul;155:79-85 - PubMed
  31. Ann Neurol. 1991 Dec;30(6):825-30 - PubMed
  32. J Affect Disord. 1989 Sep-Oct;17(2):189-95 - PubMed
  33. Psychol Med. 1992 Aug;22(3):607-15 - PubMed
  34. Am J Psychiatry. 1983 Aug;140(8):1072-4 - PubMed
  35. Am J Geriatr Psychiatry. 1994 Autumn;2(4):332-337 - PubMed
  36. Arch Neurol. 1988 Jul;45(7):725-30 - PubMed
  37. J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):55-60 - PubMed
  38. J Neuropsychiatry Clin Neurosci. 1989 Spring;1(2):135-44 - PubMed
  39. Am J Cardiol. 1998 Sep 24;82(6A):2M-4M - PubMed
  40. Am J Psychiatry. 1996 Jul;153(7):877-85 - PubMed
  41. Am J Epidemiol. 1995 Dec 15;142(12):1279-90 - PubMed
  42. Med Hypotheses. 1995 Feb;44(2):111-5 - PubMed
  43. Am J Geriatr Psychiatry. 1997 Spring;5(2):116-25 - PubMed
  44. J Neurosci. 1992 Sep;12(9):3628-41 - PubMed
  45. Arch Gen Psychiatry. 1996 Apr;53(4):305-12 - PubMed
  46. J Ment Sci. 1956 Jan;102(426):141-50 - PubMed
  47. Am J Cardiol. 1987 Dec 1;60(16):1273-5 - PubMed
  48. J Neural Transplant Plast. 1993 Jul-Sep;4(3):175-92 - PubMed
  49. J Geriatr Psychiatry Neurol. 1989 Oct-Dec;2(4):182-7 - PubMed
  50. Acta Psychiatr Scand. 1981 Nov;64(5):373-80 - PubMed
  51. Brain. 1990 Aug;113 ( Pt 4):1113-29 - PubMed
  52. Psychosomatics. 1993 Jul-Aug;34(4):364-7 - PubMed
  53. JAMA. 1996 Oct 16;276(15):1269-78 - PubMed
  54. Am J Psychiatry. 1997 Apr;154(4):497-501 - PubMed
  55. Arch Neurol. 1992 May;49(5):549-54 - PubMed
  56. Biol Psychiatry. 1988 Jun;24(2):143-61 - PubMed
  57. Adv Neurol. 1995;65:49-60 - PubMed
  58. Am J Cardiol. 1996 Feb 22;77(6):6B-11B - PubMed
  59. Biol Psychiatry. 1991 Aug 1;30(3):310-2 - PubMed
  60. Am J Psychiatry. 1993 May;150(5):713-9 - PubMed
  61. Eur Arch Psychiatry Clin Neurosci. 1993;243(1):41-6 - PubMed
  62. Br J Psychiatry. 1980 Mar;136:270-5 - PubMed
  63. Arch Neurol. 1993 Aug;50(8):818-24 - PubMed
  64. Neurology. 1995 May;45(5):865-71 - PubMed
  65. Am J Geriatr Psychiatry. 1994 Autumn;2(4):290-299 - PubMed
  66. Stroke. 1984 May-Jun;15(3):510-7 - PubMed
  67. J Affect Disord. 1990 Jul;19(3):153-62 - PubMed
  68. Stroke. 1988 Oct;19(10):1285-8 - PubMed
  69. Am J Psychiatry. 1995 Mar;152(3):341-51 - PubMed
  70. AJR Am J Roentgenol. 1988 Sep;151(3):559-66 - PubMed
  71. Arch Gen Psychiatry. 1993 Jan;50(1):7-16 - PubMed
  72. J Neurol Neurosurg Psychiatry. 1977 Oct;40(10):1018-20 - PubMed
  73. Stroke. 1993 Nov;24(11):1631-4 - PubMed
  74. Neurobiol Aging. 1991 May-Jun;12(3):245-7 - PubMed
  75. Int J Psychiatry Med. 2000;30(1):1-13 - PubMed
  76. Int J Geriatr Psychiatry. 1998 Oct;13(10):707-16 - PubMed
  77. Arch Neurol. 1990 Oct;47(10):1107-11 - PubMed
  78. Annu Rev Neurosci. 1986;9:357-81 - PubMed
  79. Am J Psychiatry. 1997 Jan;154(1):4-17 - PubMed
  80. Am J Psychiatry. 1993 Nov;150(11):1693-9 - PubMed
  81. Acta Neurol Scand. 1993 Feb;87(2):111-4 - PubMed
  82. Biol Psychiatry. 1993 Aug 1;34(3):141-5 - PubMed
  83. J Neurol Sci. 1992 Jul;110(1-2):1-7 - PubMed
  84. Biol Psychiatry. 1992 Mar 15;31(6):591-9 - PubMed
  85. Stroke. 1993 Oct;24(10):1452-7 - PubMed
  86. J Am Geriatr Soc. 1990 Oct;38(10):1133-8 - PubMed

Publication Types